ASP Isotopes forecasts FY 2026 PET Labs revenue about $14 million

ASP Isotopes forecast FY 2026 PET Labs revenue of about $14 million, versus $6 million in 2025; 1H organic revenue growth topped 50%.

Phase 2 construction is expected to start in 2H 2026 with a planned 44-month build; targeted funding includes USD 750 million of senior debt.

Phase 2 nameplate revenue potential is projected above $360 million annually, and the group's 2031 EBITDA target is set above $300 million.

Renergen helium production is expected to start before Sept. 30, 2026; Phase 1 annualized helium and LNG revenue is forecast near $27 million.

Phase 1 pricing assumptions include helium above USD 600 per Mcf and LNG at USD 15-18 per GJ; revenue recognition is expected in 2H 2026.